Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma.

about

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma.

P2860

Q26744031-A1C6287D-D52F-4A2E-88AC-7B9C31E1CF74 Q26768408-C4A3B467-C9FF-4F0E-AC96-0E34D440D34B Q38156108-7056309C-702F-41E0-AADD-B4019DADA528

P2860

Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma.

Item

http://www.wikidata.org/entity/Q42127606

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@en

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@nl

type

Item

label

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@en

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@nl

prefLabel

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@en

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@nl

P1476

Adjuvant bidirectional chemoth ...... gnant peritoneal mesothelioma.

@en

P2093

Lana Bijelic

http://www.w3.org/2001/XMLSchema#string

O Anthony Stuart

http://www.w3.org/2001/XMLSchema#string

Paul Sugarbaker

http://www.w3.org/2001/XMLSchema#string

P2860

Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

A review of peritoneal mesothelioma at the Washington Cancer Institute.

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Clinical presentation of peritoneal mesothelioma.

New strategies are needed in diffuse malignant mesothelioma.

Peritoneal mesothelioma: treatment approach based on natural history.

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

P304

890450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/890450

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230750118

http://www.w3.org/2001/XMLSchema#string

P698

22927839

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

3423889

http://www.w3.org/2001/XMLSchema#string

Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma.

about

P2860

P2860

Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932